153 related articles for article (PubMed ID: 38130284)
1. Initial Experiences in Adolescents and Young Adults with T-Cell Acute Lymphoblastic Leukemia/Lymphoma Treated with the Modified BFM 2002 Protocol in a Resource-Constrained Setting.
Jinwala P; Patidar R; Bansal S; Asati V; Shrivastava SP; Elhence A; Patel S; Chitalkar PG
South Asian J Cancer; 2023 Oct; 12(4):378-383. PubMed ID: 38130284
[TBL] [Abstract][Full Text] [Related]
2. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K
Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992
[TBL] [Abstract][Full Text] [Related]
3. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
[TBL] [Abstract][Full Text] [Related]
4. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Philadelphia Positive Acute Lymphoblastic Leukemia in Adolescent and Young Adults.
Ahmed U; Ahmed D; Awan MN; Ahmad U; Ahsan B; Iftikhar R; Mir MA; Bokhari SW
Cureus; 2022 Dec; 14(12):e32467. PubMed ID: 36644079
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy improved treatment outcome for Chinese children and adolescents with lymphoblastic lymphoma.
Sun XF; Xia ZJ; Zhen ZJ; Xiang XJ; Xia Y; Ling JY; Liu DG; Huang HQ; Zhen L; Luo WB; Lin H; Guan ZZ
Int J Clin Oncol; 2008 Oct; 13(5):436-41. PubMed ID: 18946754
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India.
Vijayasekharan K; Kc A; Prasad M; Dhamne C; Roy Moulik N; Shet T; Sridhar E; Laskar S; Kembhavi S; Shah S; Gujral S; Narula G; Banavali SD
Pediatr Hematol Oncol; 2022 Aug; 39(5):427-440. PubMed ID: 35179438
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol.
Rajendra A; Jain H; Bonda VNA; Nayak L; Tembhare P; Shetty D; Thorat J; Jain H; Subramanian PG; Patkar N; Chatterjee G; Khattry N; Gokarn A; Punatar S; Mokal S; Bagal B; Sengar M
Blood Adv; 2021 Mar; 5(5):1178-1193. PubMed ID: 33635331
[TBL] [Abstract][Full Text] [Related]
10. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Steinherz PG; Gaynon PS; Breneman JC; Cherlow JM; Grossman NJ; Kersey JH; Johnstone HS; Sather HN; Trigg ME; Uckun FM; Bleyer WA
Cancer; 1998 Feb; 82(3):600-12. PubMed ID: 9452280
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
12. Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Schober S; Arlt I; Loewke M; Henze G
Blood; 1994 Jun; 83(12):3468-72. PubMed ID: 8204875
[TBL] [Abstract][Full Text] [Related]
13. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).
Kamps WA; Bökkerink JP; Hählen K; Hermans J; Riehm H; Gadner H; Schrappe M; Slater R; van den Berg-de Ruiter E; Smets LA; de Vaan GA; Weening RS; van Weerden JF; van Wering ER; den der Does-van den Berg A
Blood; 1999 Aug; 94(4):1226-36. PubMed ID: 10438710
[TBL] [Abstract][Full Text] [Related]
14. [Outcomes of modified NHL-BFM-90 protocol for children and adolescents with lymphoblastic lymphoma].
Sun X; Zhen Z; Zhu J; Wang J; Lu S; Xia Y; Sun F; Chen Y; Zhang F; Cai R; Li P; Guo X
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1083-9. PubMed ID: 25543702
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features and prognosis of children with lymphoblastic lymphoma].
Jin L; Zhang R; Huang S; Yang J; Duan YL; Zhang YH
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):138-42. PubMed ID: 22780934
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Münster Chemotherapy in Adult Acute Lymphoblastic Leukemia.
Aladag E; Aktimur SH; Aydın Ö; Demiroglu H; Buyukasik Y; Aksu S; Ozcebe OI; Haznedaroglu IC; Sayinalp N; Turgut M; Goker H
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):147-153. PubMed ID: 33451957
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Dopfer R; Henze G; Bender-Götze C; Ebell W; Ehninger G; Friedrich W; Gadner H; Klingebiel T; Peters C; Riehm H
Blood; 1991 Nov; 78(10):2780-4. PubMed ID: 1824271
[TBL] [Abstract][Full Text] [Related]
18. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
20. Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen.
Yu H; Mi L; Qi F; Wang X; Ye Y; Li M; Wang D; Ding N; Wang X; Song Y; Zhu J; Xie Y
Aging (Albany NY); 2022 Apr; 14(7):3203-3215. PubMed ID: 35400665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
